FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021895731> ?p ?o ?g. }

• W2021895731 endingPage "298" @default.
• W2021895731 startingPage "292" @default.
• W2021895731 abstract "Introduction RO-14 is a novel ultra low molecular heparin. The purpose of this study was to evaluate the safety and pharmacodynamic profile of RO-14 in healthy males. Materials and methods We conducted a two-stage, single-center, open-label, randomized study. Two cohorts of 6 volunteers were randomly assigned to 12 single, ascending subcutaneous doses (1750-19950 IU of anti-FXa activity) in an alternating crossover fashion. Safety was assessed by spontaneous/elicited adverse events, medical examination and laboratory tests. Anti-FXa activity and anti-FIIa activity were assessed throughout the 24 hours after dosing. Dose proportionality and linearity of the anti-FXa activity were evaluated. Results All doses were well tolerated and there were no bleeding events. At the lowest dose, anti-FXa activity Amax was 0.16 (±0.02) IU/mL and AUC0-24 was 1.11 (±0.24) IU*h/mL, At the highest dose anti-FXa activity Amax was 1.67 (±0.15) IU/mL; AUC0-24 was 21.48 (±4.46) IU*h/mL and t½ was 8.05 h. Mean Tmax (all doses) was 2.86 (±0.39) h. RO-14 showed proportional and linear pharmacodynamics [normalized Amax among doses (p=0.594) and normalized AUC0-24 (p=0.092), correlations between Amax-dose (R2=0.89, p<0.001) and AUC0-24-dose (R2=0.86, p<0.001)]. Anti-FIIa activity was below the detection limit (0.1 IU/ml) at all dose levels. No clinically significant changes were observed in the platelet count, APTT, PT, TT, fibrinogen and antithrombin. Conclusions In this phase I study, RO-14 exhibited a good safety profile, anti-FXa activity for either prophylaxis or treatment of venous thromboembolism, linear pharmacodynamics, a longer elimination half-life than currently marketed low molecular weight heparin and no anti-FIIa activity." @default.
• W2021895731 created "2016-06-24" @default.
• W2021895731 creator A5002137456 @default.
• W2021895731 creator A5004556665 @default.
• W2021895731 creator A5014239140 @default.
• W2021895731 creator A5017107272 @default.
• W2021895731 creator A5022994453 @default.
• W2021895731 creator A5070763532 @default.
• W2021895731 creator A5087449922 @default.
• W2021895731 creator A5087753151 @default.
• W2021895731 date "2011-04-01" @default.
• W2021895731 modified "2023-10-17" @default.
• W2021895731 title "Safety Assessment and Pharmacodynamics of a Novel Ultra Low Molecular Weight Heparin (RO-14) in Healthy Volunteers – A First-Time-In-Human Single Ascending Dose Study" @default.
• W2021895731 cites W1537999925 @default.
• W2021895731 cites W1965773425 @default.
• W2021895731 cites W1976414763 @default.
• W2021895731 cites W1983760732 @default.
• W2021895731 cites W2008790685 @default.
• W2021895731 cites W2009216358 @default.
• W2021895731 cites W2014396085 @default.
• W2021895731 cites W2023320697 @default.
• W2021895731 cites W2074178893 @default.
• W2021895731 cites W2075196907 @default.
• W2021895731 cites W2080318130 @default.
• W2021895731 cites W2096087434 @default.
• W2021895731 cites W2110596486 @default.
• W2021895731 cites W2131229762 @default.
• W2021895731 cites W2156320702 @default.
• W2021895731 cites W2156616833 @default.
• W2021895731 cites W2313812540 @default.
• W2021895731 doi "https://doi.org/10.1016/j.thromres.2010.12.009" @default.
• W2021895731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21257196" @default.
• W2021895731 hasPublicationYear "2011" @default.
• W2021895731 type Work @default.
• W2021895731 sameAs 2021895731 @default.
• W2021895731 citedByCount "11" @default.
• W2021895731 countsByYear W20218957312012 @default.
• W2021895731 countsByYear W20218957312013 @default.
• W2021895731 countsByYear W20218957312014 @default.
• W2021895731 countsByYear W20218957312015 @default.
• W2021895731 countsByYear W20218957312016 @default.
• W2021895731 countsByYear W20218957312020 @default.
• W2021895731 countsByYear W20218957312021 @default.
• W2021895731 countsByYear W20218957312022 @default.
• W2021895731 countsByYear W20218957312023 @default.
• W2021895731 crossrefType "journal-article" @default.
• W2021895731 hasAuthorship W2021895731A5002137456 @default.
• W2021895731 hasAuthorship W2021895731A5004556665 @default.
• W2021895731 hasAuthorship W2021895731A5014239140 @default.
• W2021895731 hasAuthorship W2021895731A5017107272 @default.
• W2021895731 hasAuthorship W2021895731A5022994453 @default.
• W2021895731 hasAuthorship W2021895731A5070763532 @default.
• W2021895731 hasAuthorship W2021895731A5087449922 @default.
• W2021895731 hasAuthorship W2021895731A5087753151 @default.
• W2021895731 hasConcept C111113717 @default.
• W2021895731 hasConcept C112705442 @default.
• W2021895731 hasConcept C126322002 @default.
• W2021895731 hasConcept C142724271 @default.
• W2021895731 hasConcept C197934379 @default.
• W2021895731 hasConcept C204787440 @default.
• W2021895731 hasConcept C27081682 @default.
• W2021895731 hasConcept C2776884760 @default.
• W2021895731 hasConcept C2777288759 @default.
• W2021895731 hasConcept C2777557582 @default.
• W2021895731 hasConcept C71924100 @default.
• W2021895731 hasConcept C87813604 @default.
• W2021895731 hasConcept C98274493 @default.
• W2021895731 hasConceptScore W2021895731C111113717 @default.
• W2021895731 hasConceptScore W2021895731C112705442 @default.
• W2021895731 hasConceptScore W2021895731C126322002 @default.
• W2021895731 hasConceptScore W2021895731C142724271 @default.
• W2021895731 hasConceptScore W2021895731C197934379 @default.
• W2021895731 hasConceptScore W2021895731C204787440 @default.
• W2021895731 hasConceptScore W2021895731C27081682 @default.
• W2021895731 hasConceptScore W2021895731C2776884760 @default.
• W2021895731 hasConceptScore W2021895731C2777288759 @default.
• W2021895731 hasConceptScore W2021895731C2777557582 @default.
• W2021895731 hasConceptScore W2021895731C71924100 @default.
• W2021895731 hasConceptScore W2021895731C87813604 @default.
• W2021895731 hasConceptScore W2021895731C98274493 @default.
• W2021895731 hasIssue "4" @default.
• W2021895731 hasLocation W20218957311 @default.
• W2021895731 hasLocation W20218957312 @default.
• W2021895731 hasOpenAccess W2021895731 @default.
• W2021895731 hasPrimaryLocation W20218957311 @default.
• W2021895731 hasRelatedWork W1971830765 @default.
• W2021895731 hasRelatedWork W2004325424 @default.
• W2021895731 hasRelatedWork W2021319218 @default.
• W2021895731 hasRelatedWork W2087392466 @default.
• W2021895731 hasRelatedWork W2227061539 @default.
• W2021895731 hasRelatedWork W2399977644 @default.
• W2021895731 hasRelatedWork W2531277573 @default.
• W2021895731 hasRelatedWork W2807749624 @default.
• W2021895731 hasRelatedWork W3021369409 @default.
• W2021895731 hasRelatedWork W3174177415 @default.
• W2021895731 hasVolume "127" @default.
• W2021895731 isParatext "false" @default.
• W2021895731 isRetracted "false" @default.

• next